What are the responsibilities and job description for the Vice President, Business Development position at Alnylam Pharmaceuticals?
Alnylam, a leading biotechnology company, is looking for a Vice President of Business Development to join its Corporate Development and Strategy team. This role is reporting to Alnylam's Chief Corporate Development and Strategy Officer (CDSO) and is a hybrid role based at the company's headquarters in Cambridge, MA.
The Vice President of Business Development at Alnylam will play a crucial role in driving the company's growth and innovation. This dynamic position involves identifying, evaluating, and executing strategic transactions, including licenses, collaborations, newco creations, spinouts, and M&A, within the biotechnology or pharmaceutical industry.
The ideal candidate will have a proven track record of structuring and negotiating complex deals, delivering immediate impact and leadership across a diverse portfolio of transactions. They will utilize strong financial acumen, experience with valuation and investment structures, and excellent communication, collaboration, and leadership skills to direct idea generation and prioritize innovative constructs.
Additionally, the Vice President will manage and develop a high-performing business development team, fostering a culture of continuous learning and improvement.
Key Responsibilities
- Lead and manage all aspects of the end to end business development process, from sourcing and screening opportunities, to developing business cases and term sheets, to conducting due diligence and contract review, to closing and post-closing transfer.
- Build and maintain strong relationships with external partners, including biotech and pharma companies, academic institutions, venture capitalists, and other stakeholders.
- Work closely with internal cross-functional teams, including R&D, commercial, legal, finance, and operations, to ensure alignment and support for business development initiatives.
- Provide opportunity recommendations and market insights to the CDSO, Executive Leadership Team and the Corporate Development and Strategy Leadership Team, as well as senior management and the board of directors.
- Provide concise and accurate updates to the Executive Leadership Team, partnering closely with Research, Development and Commercial, for opportunity review, prioritization, and decision-making.
- Strategic thinker who possesses both a solid business acumen and the ability to look beyond the current state to plan strategies that take into consideration both the near term and long term business objectives of Alnylam and our external competitive and business environment. This helps the organization balance risk with opportunity potential, so we advance initiatives not merely discuss them.
- Manage and mentor a team of business development professionals and foster a culture of excellence, innovation, and collaboration.
- Demonstrate purposeful urgency, by keeping on top of the business development process, identifying opportunities and roadblocks related to effective execution, guiding the team forward, and keeping the organization apprised of progress.
- Communicate effectively across a matrix organization, by articulating the vision, purpose, and expectations of the business development initiatives, ensuring clarity and alignment at both the deal team and organizational level, reducing conflict and uncertainty, and allowing everyone to have their voices heard.
- Ability to simplify complex ideas / concepts, synthesize and summarize a complex set of facts and set opportunities within the broader strategic context
- Work with CDSO to develop and execute the strategy that will help position Alnylam as a leading biotechnology partner in our focus areas of interest.
Qualifications
About Alnylam : Alnylam Pharmaceuticals (Nasdaq : ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture : Our people-first culture is guided by our core values : fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.
